Skip to content
Contact Us
iStock-1719538609 (1) (1) iStock-1719538609 (1) (1)

Medical Monitoring Services with Precision

Navigating patient safety and trial accuracy with unwavering attention to detail.
At Precision for Medicine, our Medical Monitoring services embody our dedication to excellence in clinical trials. With a proactive approach to safeguarding patient safety and protecting the integrity of trial data, we act as your steadfast ally in clinical research. Leveraging our comprehensive expertise, we facilitate a smooth journey towards submission readiness, empowering your research with unparalleled precision and reliability.
keytasks-1

Comprehensive Medical Monitoring services

Every clinical trial demands a tailored approach to ensure safety and efficacy. Precision for Medicine provides comprehensive Medical Monitoring support throughout the entire lifecycle of a trial. Our expert teams are engaged from study start up to close out, ensuring each phase is managed with the utmost care and expertise. This visualization outlines the key tasks our medical monitors perform to safeguard your trial's integrity at every step.

Optimize your program with Medical Monitoring expertise

Our experts collaborate closely with you to develop and optimize your Clinical Development Plan (CDP) as well as individual clinical trial designs. Engage with Precision for forward-thinking medical monitoring.

  • Explore CDP Services
    clinical-program-support

    Strategic Clinical Development Planning

    Partner with our medical specialists to strategically craft and refine your CDP. Benefit from our comprehensive expertise to foresee challenges and design trials that are robust, safe, and tailored to your objectives. Let Precision guide your planning with foresight and expertise.
    Explore CDP Services
  • Explore Trial Design Services
    clinical-laboratory-support

    Enhancing Clinical Trial Design

    Harness the collective expertise of our medical, biostatistical, and operational teams to bolster your trial designs. With a specialized focus on Oncology & Rare Disease, our insights can lead to more efficient early phase trials and successful late phase outcomes.
    Explore Trial Design Services

Advance Therapeutic Breakthroughs with Precision

Explore the breadth of our expertise in therapeutics and modalities, as we lead your novel treatments in Oncology, Rare Diseases, and beyond from the groundbreaking idea to clinical realization.

Oncology Explore Rare diseases Explore Autoimmune Explore Gene Therapy Explore Cell Therapy Explore

Precision Insights in Medical Monitoring and Beyond

Stay at the forefront of research with Precision’s blog, featuring key updates and insights on medical monitoring, case studies, and more. 

Explore our blog
Read: Top Clinical Research Organizations for Rare Diseases in 2025 Top Clinical Research Organizations for Rare Diseases in 2025

Clinical Trials - Rare Diseases

Top Clinical Research Organizations for Rare Diseases in 2025

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778858, hs_child_table_id=0, hs_updated_at=1736540179119, hs_published_at=1736962071401, description=Rob Maiale is an innovative marketing leader and creative technologist who transforms complex healthcare challenges into meaningful, impactful stories. With over 15 years of experience across clinical and translational research, patient education, pharmaceuticals, and diagnostics, he merges cutting-edge technology with inspired storytelling to build award-winning brand narratives. At Precision, Rob collaborates with leading experts to translate deep scientific expertise into accessible, engaging, and culturally resonant content—connecting audiences to the future of life-changing research., avatar=Image{width=400,height=400,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Rob%20Maiale.jpg',altText='Rob Maiale',fileId=184765575245}, linkedin=https://www.linkedin.com/in/rob-maiale/, hs_name=, hs_path=, lastname=Maiale, hs_initial_published_at=1729783715853, hs_created_at=1709645745089, hs_is_edited=false, hs_deleted_at=0, name=Rob, job=, slug=rob-maiale, email=, hs_updated_by_user_id=26433386}, second={}, third={}})
  • Rob Maiale avatar

    Rob Maiale
Discover
Read: Clinical Trial Trends: Late Phase Oncology Clinical Trial Trends: Late Phase Oncology

Clinical Trials - Oncology

Clinical Trial Trends: Late Phase Oncology

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=180784353404, hs_child_table_id=0, hs_updated_at=1728665282155, hs_published_at=1736962071401, description=Natacha Grand, PhD. is a Senior Operational Strategy Director at Precision for Medicine with a decade of clinical trial experience spanning site, sponsor, and CRO perspectives. Her scientific journey began with a focus on memory T-cells and immune exhaustion before she transitioned to clinical research to drive drug development and enhance patient’s health. Natacha has played critical roles in supporting Phase I-IV clinical trials, particularly in Oncology (Solid tumors and Hematologic malignancies) and chronic viral disease (HIV and HCV) with a focus on patient diversity and decentralized services. ​, avatar=Image{width=2533,height=2669,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Photo%202022_Natacha%20Grand_zoom.jpg',altText='Photo 2022_Natacha Grand_zoom',fileId=180773105730}, lastname=Grand, hs_initial_published_at=1728665285632, hs_created_by_user_id=26433386, hs_created_at=1728665205961, hs_is_edited=false, hs_deleted_at=0, name=Natacha, job=Senior Director, Operational Strategy, slug=natacha-grand, hs_updated_by_user_id=26433386}, second={}, third={}})
  • Natacha Grand avatar

    Natacha Grand
Discover
Read: Clinical Trial Trends: Antibody-Drug Conjugates Clinical Trial Trends: Antibody-Drug Conjugates

Clinical Trials - Oncology

Clinical Trial Trends: Antibody-Drug Conjugates

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=180784353404, hs_child_table_id=0, hs_updated_at=1728665282155, hs_published_at=1736962071401, description=Natacha Grand, PhD. is a Senior Operational Strategy Director at Precision for Medicine with a decade of clinical trial experience spanning site, sponsor, and CRO perspectives. Her scientific journey began with a focus on memory T-cells and immune exhaustion before she transitioned to clinical research to drive drug development and enhance patient’s health. Natacha has played critical roles in supporting Phase I-IV clinical trials, particularly in Oncology (Solid tumors and Hematologic malignancies) and chronic viral disease (HIV and HCV) with a focus on patient diversity and decentralized services. ​, avatar=Image{width=2533,height=2669,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Photo%202022_Natacha%20Grand_zoom.jpg',altText='Photo 2022_Natacha Grand_zoom',fileId=180773105730}, lastname=Grand, hs_initial_published_at=1728665285632, hs_created_by_user_id=26433386, hs_created_at=1728665205961, hs_is_edited=false, hs_deleted_at=0, name=Natacha, job=Senior Director, Operational Strategy, slug=natacha-grand, hs_updated_by_user_id=26433386}, second={}, third={}})
  • Natacha Grand avatar

    Natacha Grand
Discover

Specialized capabilities in every stage of clinical development

Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to increase speed to market. Incorporate manufacturing expertise for advances therapies to ensure scalability. Precision can customize and converge our capabilities for your program's unique needs.

  • Discover Explore
    clinical-trial-support

    Global CRO
    Services

    Award-winning CRO with deep oncology and rare disease expertise

    Explore
  • Discover Explore
    specialty-lab-services

    Global Laboratory
    Services

    Exceptional translational and biomarker sciences with global central lab services

    Explore
  • Discover Explore
    Manufacturing

    Manufacturing
    Solutions

    Pioneers in planning, building and maintaining manufacturing at scale for pharma and biotechs.

    Explore